Pro-oxidant activity of vitamin C in drinking water ... - Ã bo Akademi
Pro-oxidant activity of vitamin C in drinking water ... - Ã bo Akademi
Pro-oxidant activity of vitamin C in drinking water ... - Ã bo Akademi
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
References18. Svirbely J, Szent-Gyorgyi A. The chemical nature <strong>of</strong> <strong>vitam<strong>in</strong></strong> C. The Biochemical Journal.1932;26:865-87019. Stone N, Meister A. Function <strong>of</strong> ascorbic acid <strong>in</strong> the conversion <strong>of</strong> prol<strong>in</strong>e to collagenhydroxyprol<strong>in</strong>e. Nature. 1962;194:555–55720. Lev<strong>in</strong>e M. New concepts <strong>in</strong> the biology and biochemistry <strong>of</strong> ascorbic acid. N Engl J Med.1986;314:892-90221. Kallner AB, Hartmann D, Hornig DH. On the requirements <strong>of</strong> ascorbic acid <strong>in</strong> man:Steady-state turnover and body pool <strong>in</strong> smokers. Am J Cl<strong>in</strong> Nutr. 1981;34:1347-135522. Hornig D. Metabolism and requirements <strong>of</strong> ascorbic acid <strong>in</strong> man. S Afr Med J. 1981;60:818-82323. Johnston CS. Biomarkers for establish<strong>in</strong>g a tolerable upper <strong>in</strong>take level for <strong>vitam<strong>in</strong></strong> C. NutrRev. 1999;57:71-7724. Paul<strong>in</strong>g L. Are recommended daily allowances for <strong>vitam<strong>in</strong></strong> C adequate? <strong>Pro</strong>c Natl Acad Sci US A. 1974;71:4442-444625. Paul<strong>in</strong>g L. Vitam<strong>in</strong> C therapy <strong>of</strong> advanced cancer. N Engl J Med. 1980;302:694-69526. Moertel CG, Flem<strong>in</strong>g TR, Creagan ET, Rub<strong>in</strong> J, O'Connell MJ, Ames MM. High-dose<strong>vitam<strong>in</strong></strong> C versus placebo <strong>in</strong> the treatment <strong>of</strong> patients with advanced cancer who have hadno prior chemotherapy. A randomized double-bl<strong>in</strong>d comparison. N Engl J Med.1985;312:137-14127. Paul<strong>in</strong>g L, Herman ZS. Criteria for the validity <strong>of</strong> cl<strong>in</strong>ical trials <strong>of</strong> treatments <strong>of</strong> cohorts <strong>of</strong>cancer patients based on the Hard<strong>in</strong> Jones pr<strong>in</strong>ciple. <strong>Pro</strong>c Natl Acad Sci U S A.1989;86:6835-683728. Hemila H. Vitam<strong>in</strong> C supplementation and common cold symptoms: Factors affect<strong>in</strong>g themagnitude <strong>of</strong> the benefit. Med Hypotheses. 1999;52:171-17829. Douglas RM, Hemila H, D'Souza R, Chalker EB, Treacy B. Vitam<strong>in</strong> C for prevent<strong>in</strong>g andtreat<strong>in</strong>g the common cold. Cochrane Database Syst Rev. 2004:CD00098030. Douglas RM, Hemila H. Vitam<strong>in</strong> C for prevent<strong>in</strong>g and treat<strong>in</strong>g the common cold. PLoSMed. 2005;2:e168; quiz e21731. Machefer G, Groussard C, Rannou-Bekono F, Zouhal H, Faure H, V<strong>in</strong>cent S, Cillard J,Gratas-Delamarche A. Extreme runn<strong>in</strong>g competition decreases blood anti<strong>oxidant</strong> defensecapacity. J Am Coll Nutr. 2004;23:358-36432. Stahl W, Sies H. Anti<strong>oxidant</strong> defense: Vitam<strong>in</strong>s E and C and carotenoids. Diabetes. 1997;46Suppl 2:S14-1833. Frei B. On the role <strong>of</strong> <strong>vitam<strong>in</strong></strong> C and other anti<strong>oxidant</strong>s <strong>in</strong> atherogenesis and vasculardysfunction. <strong>Pro</strong>c Soc Exp Biol Med. 1999;222:196-20450
Change language